← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2002First marketed drug
Apr 2, 2013First NDA
Apr 2, 2013Last known activity
Oct 1, 2023
Timeline
1960s
- Jan 1, 1962
Stallergenes— Founded
2010s
- Apr 2, 2013
sweet vernal, orchard, perennial rye, timothy, and kentucky blue grass mixed pollens allergen extract— NDA Organization
- Jun 1, 2015
Greer Laboratories— Acquired
Drugs by trial phase (7 distinct, 25 trials)
Phase 3 (3 own, 1 via acquisition)
Phase 2 (1 own, 1 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Indications
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (21)
- NCT05668390Lead sponsorPhase 3Oct 1, 2023
- NCT02443805Lead sponsorPhase 3Sep 1, 2015
- NCT01930461Lead sponsorPhase 2Sep 1, 2013
- NCT01919554Lead sponsorPhase 1Jul 1, 2013
- NCT01608243Lead sponsorPhase 1May 1, 2012
- NCT01527188Lead sponsorPhase 2Jan 1, 2011
- NCT01731249Lead sponsorPhase 3Nov 1, 2010
- NCT01199133Lead sponsorPhase 3Oct 1, 2009
- NCT00803244Lead sponsorPhase 3Jan 1, 2009
- NCT01224834Lead sponsorPhase 1Jan 1, 2009
- NCT00955825Lead sponsorPhase 3Oct 1, 2008
- NCT00901914Lead sponsorPhase 2Oct 1, 2008
- NCT00889460Lead sponsorPhase 1Nov 1, 2007
- NCT00674700Lead sponsorPhase 2/Phase 3Oct 1, 2007
- NCT00660452Lead sponsorPhase 3Oct 1, 2007
Details
- Founded
- Antony, Hauts-de-Seine, FR Jan 1, 1962
- First NDA
- Apr 2, 2013
- Last known activity
- Oct 1, 2023